Consolidated Statements of Cash Flow (USD $) In Thousands, unless otherwise specified	3 Months Ended		12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net income available to common stockholders	$ 1,025	$ 1,318
Net income attributable to non-controlling interest	298	4,105
Net (loss) income attributable to VIE subordinated note holders	(3,518)	429
Net (loss) income	(2,195)	5,852
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Net realized gain – trading securities	(142)	(155)
Net realized loss - loans	(952)	0
Increase/(decrease) in other liabilities and accrued expenses	14,156	(88)
Change in unrealized appreciation – trading securities	(516)	(558)
Change in unrealized (appreciation) depreciation – derivatives	249	(1,640)
Income from investments in partially-owned entities, net	(344)	(89)
Deferred tax expense	343	1,251
Increase in other assets	(914)	(1,049)
Non cash incentive fee	16	0
Non cash compensation expense	53	92
Non cash interest from investments in loans	(99)	(38)
Accretion of discounts and depreciation expense	1,498	1,857
Amortization and write off of deferred financing costs	60	13
Accretion of mortgage note discount	(73)	5
(Decrease)/increase in policy liabilities	(2,946)	2,475
Operating activities from VIEs	35,195	1,293
Net cash provided by operating activities	44,092	10,861
Cash flows from investing activities:
Purchases of subsidiaries	(524)	(9,833)
Purchases of trading securities and loans carried at fair value	(52,372)	(24,668)
Purchases of available for sale securities	(2,429)	0
Purchases of real estate	(313)	(97)
Purchases of loans	(2,700)	(17,258)
Purchases of fixed assets	(2)	(2)
Increase in restricted cash	(9,834)	(215)
Acquisitions, net cash	7,213	(2,114)
Proceeds from mortgages held for sale	5,606	0
Proceeds from loan repayments	303	277
Proceeds from sales of trading securities	35,064	20,508
Proceeds from loans receivable	0	(1,224)
Proceeds from foreign exchange	0	45
Proceeds from sales of available for sale securities	2,601	2,590
Proceeds from maturities of available for sale securities	0	12
Proceeds from distributions paid by partially owned entities	278	0
Increase in policy loans	2,807	(2,461)
Change due to consolidation of trusts	(34)	0
Investing activities from VIEs	15,384	(347,196)
Net cash provided by /(used in) investing activities	1,048	(381,636)
Cash flows from financing activities:
Capital distributions paid by subsidiaries			0	(810)
Principal payments under mortgage notes payable			(422)	(371)
Partial paydown of borrowings			(7,160)	(1,250)
Repurchase of common stock of subsidiary			0	(2)
Payment of placement costs			(200)	(38)
Proceeds from issuance of common units of subsidiaries			400	0
Proceeds from borrowings			6,598	0
Financing activities from VIEs			(40,089)	345,938
Net cash (used in)/provided by financing activities			(40,873)	343,467
Net increase/(decrease) in cash			4,267	(27,308)
Cash and cash equivalents – unrestricted – beginning of period	120,557	88,563	88,563
Cash and cash equivalents – unrestricted – end of period	124,824	61,255	120,557	88,563
Supplemental disclosure of cash flow information:
Cash paid for interest			10,295	8,128
Cash paid for taxes			782	0
Non-cash investing and financing activities:
Capital change due to equity compensation			53	21
Net assets related to acquisitions			(3,275)	0
Non-cash financing costs	$ 0	$ 2,500